CIK 1442276
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2019-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 42.31% | 17 |
| Pharmaceuticals & Biotechnology | 21.33% | 10 |
| Insurance | 16.53% | 6 |
| Health Care Equipment & Supplies | 13.16% | 5 |
| Life Sciences Tools & Services | 4.19% | 2 |
| Health Care Providers & Services | 2.48% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | AUDENTES THERAPEUTICS INC. | Unclassified | 7.65% | |
| 2 | ALEXION PHARMACEUTICALS INC | Unclassified | 6.54% | |
| 3 | Allena Pharmaceuticals, Inc. | Unclassified | 5.57% | |
| 4 | GILD | GILEAD SCIENCES, INC. | Health Care | 5.08% |
| 5 | PEN | Penumbra Inc | Health Care | 4.37% |
| 6 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Health Care | 3.96% |
| 7 | BIIB | BIOGEN INC. | Health Care | 3.92% |
| 8 | NEVRO CORP | Unclassified | 3.81% | |
| 9 | ELV | Elevance Health, Inc. | Financials | 3.62% |
| 10 | HUM | HUMANA INC | Financials | 3.55% |
24/41 names classified · sector 57.7% of weight · industry 57.7% · mkt cap 54.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 57.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 49% of book weight classified — the grid is NOT representative of the whole book.
Classified: 49.2% of book weight (20/26 names) · unclassified 50.8%: , CNC, NVS, ICLR, IRTC, LAB. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | AUDENTES THERAPEUTICS INC. | 17,795 | $1M | 7.6% | TRIM −30% |
| 2 | ALEXION PHARMACEUTICALS INC | 8,421 | $911,000 | 6.5% | TRIM −62% |
| 3 | Allena Pharmaceuticals, Inc. | 284,285 | $776,000 | 5.6% | HOLD |
| 4 | GILDGILEAD SCIENCES INC | 10,898 | $708,000 | 5.1% | TRIM −62% |
| 5 | PENPENUMBRA INC | 3,699 | $608,000 | 4.4% | TRIM −71% |
| 6 | ZBHZIMMER BIOMET HOLDINGS INC | 3,689 | $552,000 | 4.0% | TRIM −79% |
| 7 | BIIBBIOGEN INC | 1,839 | $546,000 | 3.9% | NEW |
| 8 | NEVRO CORP | 4,515 | $531,000 | 3.8% | TRIM −22% |
| 9 | ELVELEVANCE HEALTH INC FORMERLY | 1,669 | $504,000 | 3.6% | NEW |
| 10 | HUMHUMANA INC | 1,347 | $494,000 | 3.5% | NEW |
| 11 | CITHE CIGNA GROUP | 2,216 | $453,000 | 3.3% | TRIM −69% |
| 12 | IQVIQVIA HLDGS INC | 2,926 | $452,000 | 3.2% | TRIM −66% |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC | 5,329 | $451,000 | 3.2% | TRIM −82% |
| 14 | AERIE PHARMACEUTICALS INC | 18,035 | $436,000 | 3.1% | ADD 8% |
| 15 | ALLERGAN PLC | 2,282 | $436,000 | 3.1% | TRIM −69% |
| 16 | ARENA PHARMECEUTICALS INC | 9,484 | $431,000 | 3.1% | TRIM −67% |
| 17 | CNCCENTENE CORP DEL | 6,838 | $430,000 | 3.1% | NEW |
| 18 | NVSNOVARTIS AG | 4,270 | $392,000 | 2.8% | TRIM −60% |
| 19 | HCAHCA HEALTHCARE INC | 2,335 | $345,000 | 2.5% | TRIM −69% |
| 20 | PFEPFIZER INC | 7,492 | $294,000 | 2.1% | NEW |
| 21 | ICUIICU MED INC | 1,381 | $258,000 | 1.9% | NEW |
| 22 | DERMIRA INC | 16,892 | $256,000 | 1.8% | TRIM −44% |
| 23 | ICLRICON PLC | 1,402 | $241,000 | 1.7% | TRIM −56% |
| 24 | UNHUNITEDHEALTH GROUP INC | 791 | $233,000 | 1.7% | NEW |
| 25 | IRTCIRHYTHM HOLDINGS INC | 3,389 | $231,000 | 1.7% | TRIM −73% |
| 26 | IMMUNOMEDICS INC | 10,880 | $230,000 | 1.7% | NEW |
| 27 | ABTABBOTT LABS | 2,565 | $223,000 | 1.6% | NEW |
| 28 | MOHMOLINA HEALTHCARE INC | 1,387 | $188,000 | 1.3% | TRIM −81% |
| 29 | EWEDWARDS LIFESCIENCES CORP | 788 | $184,000 | 1.3% | TRIM −79% |
| 30 | LABSTANDARD BIOTOOLS INC | 37,856 | $132,000 | 0.9% | ADD 7% |
| 31 | CATALENT INC | 2,231 | $126,000 | 0.9% | TRIM −84% |
| 32 | MORPHOSYS AG | 994 | $126,000 | 0.9% | NEW |
| 33 | ABBVABBVIE INC | 1,269 | $112,000 | 0.8% | NEW |
| 34 | AXONICS INC | 3,978 | $110,000 | 0.8% | ADD 105% |
| 35 | CARDIOVASCULAR SYSTEMS INC | 1,985 | $96,000 | 0.7% | TRIM −66% |
| 36 | VRTXVERTEX PHARMACEUTICALS INC | 434 | $95,000 | 0.7% | NEW |
| 37 | HALOHALOZYME THERAPEUTICS INC | 4,650 | $82,000 | 0.6% | NEW |
| 38 | Amarin Corp PLC | 3,757 | $81,000 | 0.6% | NEW |
| 39 | CHRSCOHERUS ONCOLOGY INC | 3,771 | $68,000 | 0.5% | TRIM −52% |
| 40 | ACORDA THERAPEUTICS INC. | 18,342 | $37,000 | 0.3% | TRIM −8% |
| 41 | ENDOLOGIX INC | 2,440 | $4,000 | 0.0% | TRIM −15% |
Where this firm's principals came from and which firms its alumni went on to found.
